BioSpace News Archive

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today plans to report first quarter 2018 financial results on May 8, 2018. Ligand’s CEO John Higgins, President and COO Matt Foehr and Executive Vice President and CFO Matt Korenberg will host the conference call.

Healthcare Informatics Company with Proven Products to Enhance Diagnosis Will Partner with End-to-End DCT Platform, Offering Patients and Healthcare Providers a Trusted Medical Resource for Diagnosing Skin Conditions

Eli Lilly and Company announced financial results for the first quarter of 2018.

Evofem Biosciences, Inc., (NASDAQ: EVFM) (“Evofem” or the “Company”), a clinical-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women’s sexual and reproductive health, announced today the launch of an underwritten public offering of $40.0 million of its common stock

Waters Corporation (NYSE: WAT) today announced first quarter 2018 sales of $531 million, a 7% increase as reported, versus sales of $498 million for the first quarter of 2017. Foreign currency translation increased year-over-year sales growth by approximately 5% for the quarter.

Gateway for Cancer Research announces the completion of a Phase I clinical project led by Dr. Sarah Leary, pediatric oncologist at Seattle Children’s Hospital.

Reductions in annualized relapse rates shown in pivotal trials with ozanimod were consistent in subgroups including baseline disability, gadolinium-enhanced lesion status and prior exposure to disease-modifying therapies versus interferon beta-1a

Essa is a pharmaceutical company focused on the development of novel small molecule drugs for the treatment of prostate cancer.

Five-minute, office-based alternative to endoscopy utilizes highly accurate DNA biomarkers to detect Barrett’s Esophagus, the precursor to a common highly lethal form of esophageal cancer

ReShape Lifesciences Inc. announced that the ReShape Balloon™ was granted registration by the National Health Regulation Authority (NHRA) in the Kingdom of Bahrain.